Progenie molecular is a biomedical company specialized in molecular diagnostics. We use the latest biotechnology to perform the following activities:
- Molecular diagnostic tests and genetic identification.
- Products for in vitro diagnostics and research
The company is organized in 2 functional units.
Progenie molecular aims to develop and implement innovative solutions for the diagnosis, prevention and monitoring of diseases.
Our desire is to help those who are affected by a disease and professionals of health in making clinical decisions, while providing technological development of our society.
To do this we rely on innovation, professionalism, quality and desire for improvement... always focused on the most important: the health of people.
The company is headed by Diego Arroyo. Diego is a molecular biologist with extensive experience in the biomedical sector. He holds a PhD in Biochemistry and Molecular Biology by the Autonomous University of Barcelona.
Diego began his scientific track record at the Spanish National Research Council (CSIC), where he conducted research work for six years in the Molecular Genetics Dept. of the Molecular Biology Institute of Barcelona. He continued his scientific career at the laboratory of retrovirus of the Hospital Germans Trias i Pujol (Can Ruti) of Badalona. Afterwards he led for two years the molecular biology laboratory in an important special techniques laboratory.
Laura Ruiz is a biologist and has a degree in Biochemistry and molecular biology by the Autonomous University of Madrid (UAM). During the degree she took an internship at the Department of Cytology and Histology of the UAM.
She earned her PhD at the Department of Biochemistry of the Faculty of Medicine of the UAM, and worked as a researcher at the Molecular Genetics Unit of the Ramon y Cajal Hospital in Madrid for 6 years until the end of the thesis in 2012.
Laura is a member of the Spanish Association of Human Genetics (AEGH), Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Molecular Diagnostics (SEDM).
Since 2015 she leads the R & D Department of Progenie molecular and currently as the technical manager.
Progenie molecular has its modern facilities in an exclusive building of 600 m2, of which nearly 200 m2 are dedicated to a laboratory equipped with the latest equipment to carry out the most modern techniques of molecular diagnosis and genetic identification.
We are in the city of Valencia, close to the Hospital 9 de Octubre and the Bioparc, in an environment with numerous centers of the health sector.
Progenie molecular has two certified quality systems: ISO 9001:2008 and ISO 13485:2003 covering the following activities:
All technical work is verified by biological controls provided by independent organizations such as NIBSC (National Institute for Biological Standards and Controls) QCMD (Quality Control for Molecular Diagnostics) and QNOSTICS.
The company participates in external quality exercises from different groups and organizations, such as Spanish and Portuguese Group of the International Society for Forensic Genetics (ISFG-GHEP).
Spanish Association of Human Genetics (AEGH)
European Society of Human Genetics (ESHG)
Spanish Soc. Infectious Dis. and Clin. Micro. (SEIMC)
Spanish Society of Virology (SEV)
International Soc. Forensic Genetics (ISFG)
European Soc. Clin. Micro. and Infectious Dis. (ESCMID)
Spanish Society of Molecular Diagnostics (SEDM)
Spanish Assoc. Cervical Path. and Colposcopy (AEPCC)
European Directory Diagnostic DNA Labs (EDDNAL)
Progenie molecularis a company licensed by the Spanish Agency of Medicines and Health Products (AEMPS) for the production of in vitro diagnostic reagents.
Our products comply with European Directive 98/79/EC about in vitro diagnostic, and the Royal Decrees 1662/2000 and 1591/2009 regulating the manufacture of medical devices in Spain.
Progenie molecular is a lab accredited for molecular diagnosis of genetic and infectious diseases (registration No. 5568-GV).
This authorization is required to process clinical samples and the issuance of a clinical report with the result.
As a registered laboratory, our facilities are subject to regulatory requirements and regular inspections carried out by health administrations.
Progenie molecular complies with all legal requirements regarding data protection, prevention of occupational hazards and toxic waste management.